Literature DB >> 21929531

Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.

H H van der Zee1, L de Ruiter, J Boer, D G van den Broecke, J C den Hollander, J D Laman, E P Prens.   

Abstract

BACKGROUND: Current insight into the histopathological course of events during disease progression in hidradenitis suppurativa (HS) is fragmentary.
OBJECTIVES: To identify histological alterations and leucocyte subsets in normal-appearing perilesional skin, and early and chronic HS lesions.
METHODS: In this observational study we examined eight perilesional skin samples, and six early and 10 chronic prototypic HS lesions, as well as skin samples from four healthy donors using in situ immunostaining.
RESULTS: Perilesional skin showed mild psoriasiform hyperplasia and follicular plugging as well as a low-grade influx of tryptase-positive mast cells, CD3+ T cells, CD138+ plasma cells and factor XIIIa+ dendritic cells. In early HS lesions, neutrophilic abscess formation and influx of mainly macrophages, monocytes and dendritic cells predominated. In chronic disease, the infiltrate expanded with markedly increased frequencies of CD20+ and CD79a+ B cells and CD138+ plasma cells. As in early lesions, free keratin fibres were detected in the dermis and within giant cells. Single detached keratinocytes and strands of follicular epithelium were observed in the dermis, the latter frequently expressing Ki67, indicative of active proliferation.
CONCLUSIONS: Psoriasiform hyperplasia, follicular plugging and low-grade leucocytic infiltration are already present in normal-appearing perilesional skin. Keratin fibres in the dermis are associated with clinical disease. Early lesions are characterized by neutrophilic abscess formation and influx of mainly histiocytes, and chronic lesions mainly by expansion of B cells and plasma cells in 'pseudo' follicles. Proliferating strands of follicular epithelium may initiate fistula formation. Mast cells are increased in all stages of HS including perilesional skin.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929531     DOI: 10.1111/j.1365-2133.2011.10643.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  37 in total

1.  Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Authors:  S Hessam; M Sand; M Skrygan; T Gambichler; F G Bechara
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.

Authors:  Weibin Shi; Shannon Schultz; Amy Strouse; David R Gater
Journal:  BMJ Case Rep       Date:  2019-01-20

3.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960

4.  The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls.

Authors:  Hans Christian Ring; Jonathan Thorsen; Ditte M Saunte; Berit Lilje; Lene Bay; Peter Theut Riis; Niels Larsen; Lee O'Brien Andersen; Henrik V Nielsen; Iben M Miller; Thomas Bjarnsholt; Kurt Fuursted; Gregor Borut Jemec
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

Review 5.  Miscellaneous Perianal Afflictions.

Authors:  Gonzalo F Hagerman; Jorge Silva-Velazco; Juan Francisco Molina-Lopez
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

Review 6.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

7.  Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa.

Authors:  Cindy Orvain; Yea-Lih Lin; Francette Jean-Louis; Hakim Hocini; Barbara Hersant; Yamina Bennasser; Nicolas Ortonne; Claire Hotz; Pierre Wolkenstein; Michele Boniotto; Pascaline Tisserand; Cécile Lefebvre; Jean-Daniel Lelièvre; Monsef Benkirane; Philippe Pasero; Yves Lévy; Sophie Hüe
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

8.  Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163+ macrophages.

Authors:  A S Byrd; M L Kerns; D W Williams; J C Zarif; A Z Rosenberg; M Delsante; H Liu; C A Dillen; J P Maynard; J A Caffrey; J M Sacks; S M Milner; O Aliu; K P Broderick; L S Lew; L S Miller; S Kang; G A Okoye
Journal:  Br J Dermatol       Date:  2018-06-29       Impact factor: 9.302

9.  Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.

Authors:  Rahel Thomi; Simone Cazzaniga; S Morteza Seyed Jafari; Christoph Schlapbach; Robert E Hunger
Journal:  JAMA Dermatol       Date:  2018-05-01       Impact factor: 10.282

Review 10.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.